Literature DB >> 2373200

Production of active and passive anaphylactic shock in the WBB6F1 mouse, a mast cell-deficient strain.

A Arimura1, M Nagata, A Watanabe, K Nakamura, M Takeuchi, M Harada.   

Abstract

The role of mast cells in active and passive anaphylactic shock was examined using the WBB6F1 mouse, a genetically mast cell-deficient strain. Lethal anaphylactic shock occurred at high incidence rates in mice actively sensitized to bovine serum albumin (BSA). The reaction was specific to BSA since the shock could not be elicited by human or guinea pig serum albumin in these animals. Lethal shock could be prevented by CV-3988 but not by cyproheptadine, which suggests that the shock is mediated by PAF but not by histamine and serotonin. Similarly, lethal shock was provoked by homologous antigens in mice which had been passively sensitized with allogeneic anti-benzylpenicilloyl (BPO) IgG1 monoclonal antibody or with allogeneic or xenogeneic anti-BSA antiserum, but not in those sensitized with allogeneic anti-BPO IgE monoclonal antibody. These findings suggest that mast cells are not necessarily required for anaphylactic shock in the mouse.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2373200     DOI: 10.1007/bf01939952

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


  9 in total

Review 1.  Behaviour of mouse mast cells during anaphylaxis in vitro.

Authors:  N M Vaz; A Prouvost-Danon
Journal:  Prog Allergy       Date:  1969

Review 2.  Platelet-activating factor as a mediator of allergic disease.

Authors:  P J Barnes; K F Chung; C P Page
Journal:  J Allergy Clin Immunol       Date:  1988-05       Impact factor: 10.793

Review 3.  Basophils and mast cells: morphologic insights into their biology, secretory patterns, and function.

Authors:  S J Galli; A M Dvorak; H F Dvorak
Journal:  Prog Allergy       Date:  1984

4.  A quantitative assay of covalently bound cephalosporin derivatives in cephalosporin-protein conjugates.

Authors:  M Ebata; Y Miyake; J Uchida
Journal:  J Antibiot (Tokyo)       Date:  1976-06       Impact factor: 2.649

5.  Biology of immunoglobulin E. Molecular basis of reaginic hypersensitivity.

Authors:  T Ishizaka; K Ishizaka
Journal:  Prog Allergy       Date:  1975

6.  A lethal role of platelet activating factor in anaphylactic shock in mice.

Authors:  Z Terashita; Y Imura; A Shino; K Nishikawa
Journal:  J Pharmacol Exp Ther       Date:  1987-10       Impact factor: 4.030

7.  Decrease of mast cells in W/Wv mice and their increase by bone marrow transplantation.

Authors:  Y Kitamura; S Go; K Hatanaka
Journal:  Blood       Date:  1978-08       Impact factor: 22.113

8.  Mouse anti-benzylpenicilloyl IgE monoclonal antibody: preparation, characterization and cross-reactivity.

Authors:  H Fukushima; R Misaki; M Takeuchi; Y Niinomi; M Harada
Journal:  Clin Exp Immunol       Date:  1987-05       Impact factor: 4.330

9.  Studies on the mechanism of the formation of the penicillin antigen. III. The N-(D-alpha-benzylpenicilloyl) group as an antigenic determinant responsible for hypersensitivity to penicillin G.

Authors:  B B LEVINE; Z OVARY
Journal:  J Exp Med       Date:  1961-12-01       Impact factor: 14.307

  9 in total
  3 in total

1.  Occurrence of disseminated intravascular coagulation (DIC) in active systemic anaphylaxis: role of platelet-activating factor.

Authors:  I H Choi; T Y Ha; D G Lee; J S Park; J H Lee; Y M Park; H K Lee
Journal:  Clin Exp Immunol       Date:  1995-06       Impact factor: 4.330

2.  Human FcγRIIA induces anaphylactic and allergic reactions.

Authors:  Friederike Jönsson; David A Mancardi; Wei Zhao; Yoshihiro Kita; Bruno Iannascoli; Huot Khun; Nico van Rooijen; Takao Shimizu; Lawrence B Schwartz; Marc Daëron; Pierre Bruhns
Journal:  Blood       Date:  2011-12-02       Impact factor: 22.113

3.  Immunoglobulin E-dependent active fatal anaphylaxis in mast cell-deficient mice.

Authors:  I H Choi; Y M Shin; J S Park; M S Lee; E H Han; O H Chai; S Y Im; T Y Ha; H K Lee
Journal:  J Exp Med       Date:  1998-11-02       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.